Inspire Medical Systems (INSP) shares jumped about 15% in recent Tuesday trading after Wells Fargo upgraded the stock following better-than-expected Q3 results.
Wells Fargo upgraded the stock to overweight from equalweight and adjusted its price target to $90 per share from $101.
Inspire Medical Systems reported Q3 adjusted earnings late Monday of $0.38 per diluted share, down from $0.60 a year earlier. Analysts polled by FactSet expected a loss of $0.19.
Revenue for the three months ended Sept. 30 was $224.5 million, up from $203.2 million a year earlier. Analysts surveyed by FactSet expected $220.4 million.
The company now expects full-year 2025 diluted EPS of $0.90 to $1, versus $0.40 to $0.50 earlier. Analysts surveyed by FactSet expect EPS of $0.77.
The company maintained its 2025 revenue guidance of $900 million to $910 million. Analysts surveyed by FactSet expect $906.4 million.
Price: 84.75, Change: +11.04, Percent Change: +14.98